Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value ...

Warren Buffett’s Berkshire Hathaway BRK.A BRK.B just filed its 13F for the first quarter of 2025. Here’s a look at the stocks ...

When we talk about measuring a company’s financial health, most investors and analysts immediately turn to the familiar ...

Downgraded Cabot Corporation to 'Hold' due to muted growth and poor near-term EPS revisions; Q1 report confirmed growth ...

But capital operation should not be a performance show, it should be a sculpture of value. Goheal has always believed that ...